United Pharm (033270) — Cash Flow-to-Debt Ratio
United Pharm (033270) has a Cash Flow-to-Debt Ratio of 0.35x as of December 2025, meaning its operating cash flow of ₩23.01 Billion could theoretically repay 0% of its total liabilities (₩64.86 Billion) in one year. See United Pharm (033270) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
United Pharm Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for United Pharm across 14 annual periods. Also explore 033270 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for United Pharm (2011–2025)
Year-by-year debt coverage analysis for United Pharm. For market capitalisation and broader financial context, see market value of United Pharm.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.79x | ₩51.14 Billion | ₩64.86 Billion | ▲ +99.3% |
| 2024 | 0.40x | ₩26.79 Billion | ₩67.72 Billion | ▼ -28.3% |
| 2023 | 0.55x | ₩49.77 Billion | ₩90.18 Billion | ▼ -30.7% |
| 2022 | 0.80x | ₩63.78 Billion | ₩80.03 Billion | ▲ +43.4% |
| 2021 | 0.56x | ₩44.09 Billion | ₩79.32 Billion | ▲ +15.1% |
| 2020 | 0.48x | ₩36.96 Billion | ₩76.54 Billion | ▼ -3.6% |
| 2019 | 0.50x | ₩38.15 Billion | ₩76.14 Billion | ▼ -0.1% |
| 2018 | 0.50x | ₩36.86 Billion | ₩73.47 Billion | ▲ +16.2% |
| 2017 | 0.43x | ₩27.68 Billion | ₩64.11 Billion | ▼ -18.3% |
| 2016 | 0.53x | ₩30.02 Billion | ₩56.83 Billion | ▲ +37.0% |
| 2014 | 0.39x | ₩21.31 Billion | ₩55.27 Billion | ▲ +5.9% |
| 2013 | 0.36x | ₩18.97 Billion | ₩52.10 Billion | ▼ -10.0% |
| 2012 | 0.40x | ₩21.88 Billion | ₩54.10 Billion | ▼ -16.5% |
| 2011 | 0.48x | ₩27.62 Billion | ₩57.04 Billion | — |